INDV
NASDAQ · Pharmaceuticals
Indivior Pharmaceuticals Inc
$28.21
+0.06 (+0.21%)
Performance
1D
—
1W
-20.24%
1M
-21.92%
3M
-26.67%
6M
-27.37%
1Y
-11.48%
YTD
-21.05%
Open$26.81
Previous Close$28.15
Day High$28.99
Day Low$26.74
52W High$42.81
52W Low$24.74
Volume—
Avg Volume2.48M
Market Cap4.20B
P/E Ratio11.84
EPS$2.78
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$35.18
Below
SMA 200
$35.68
Below
RSI (14)
55
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
10 analysts
Price Target
+71.9% upside
Current
$28.21
$28.21
Target
$48.50
$48.50
$40.68
$48.50 avg
$71.11
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.17B | 1.05B | 1.33B |
| Net Income | 198.26M | 160.47M | 235.99M |
| Profit Margin | 17.0% | 16.1% | 17.8% |
| EBITDA | 247.37M | 211.33M | 342.24M |
| Free Cash Flow | — | — | 277.67M |
| Rev Growth | +11.2% | +11.2% | +22.2% |
| Debt/Equity | 5.43 | 5.43 | 0.27 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,364.73 | -3.76% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $272.32 | -1.45% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $146.94 | -2.27% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.88 | -2.96% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $63.13 | -1.65% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $82.11 | -7.95% | 12.3 | 32.24B |